Evidence map›Paper›PMID 42671266›Full record

ArticleJournal of immunology research2026

HLA-A

Emily A Cowen, Samantha Brown, Rachel E Reingold, Sarah Samorodnitsky, Maira Fonseca, Joseph R Stoll, Sean M Devlin, James W Young, Samira A Fatmi, Molly Maloy and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emily A CowenDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0002-8616-3542
Samantha BrownDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0001-5352-974X
Rachel E ReingoldDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0009-0008-4094-1346
Sarah SamorodnitskyDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0001-7909-0245
Maira FonsecaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
Joseph R StollDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
Sean M DevlinDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0002-6801-720X
James W YoungAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0002-0032-6559
Samira A FatmiAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
Molly MaloyAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0001-9831-3416
Sergio GiraltAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0003-1944-5053
Doris M PonceAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0002-9422-5766
Ann A JakubowskiAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.
Alina MarkovaDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA, mskcc.org.ORCID https://orcid.org/0000-0002-2427-3199

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NIH/NCI Cancer Center P30-CA008748
6 · The paper itself

Abstract

Acute graft-versus-host disease (aGvHD) remains a substantial cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). Limited studies explore the association between specific major histocompatibility complex (MHC) alleles and aGvHD or transplant-related mortality (TRM). After a noted clinical trend of higher TRM among a series of patients with aGvHD and MHC class I HLA-

Indexed as

AllelesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHLA-A AntigensAdolescentAdultAgedFemaleHistocompatibilityHistocompatibility TestingHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTransplantation, HomologousHLA-A Antigensacute graft-versus-host-diseaseallogeneic hematopoietic stem cell transplanthematologic neoplasmsHLA-A1 antigenhuman leukocyte antigentransplant-related mortality

Identifiers

PMID42671266
PMCPMC13528444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.